Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8681722 | Clinical Neurology and Neurosurgery | 2018 | 8 Pages |
Abstract
Unfavorable outcome was observed in 14 patients (31.11%) which was lower than we expected. Interestingly, non-pure DAI was no worse than pure DAI on their functional outcome. However, DAI Stage III was independently associated with poor outcome when compared to Stage I or I and II. Finally, we concluded that Stage II is clinically more related to Stage I, rather than Stage III.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Moinay Kim, Jae Sung Ahn, Wonhyoung Park, Suk Kyung Hong, Sang Ryong Jeon, Sung Woo Roh, Seungjoo Lee,